RHUMBLINE ADVISERS - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$5,782,945
-15.8%
364,396
+0.1%
0.01%
-12.5%
Q2 2023$6,867,679
+557794.3%
363,947
+13.6%
0.01%
+300.0%
Q1 2023$1,231
-23.1%
320,502
-0.6%
0.00%0.0%
Q4 2022$1,600
-99.9%
322,548
+1.0%
0.00%0.0%
Q3 2022$1,526,000
+13.5%
319,328
+6.9%
0.00%0.0%
Q2 2022$1,344,000
+12.0%
298,672
+18.5%
0.00%0.0%
Q1 2022$1,200,000
-39.7%
252,088
-6.0%
0.00%0.0%
Q4 2021$1,991,000
+29.3%
268,320
-1.2%
0.00%0.0%
Q3 2021$1,540,000
-12.5%
271,606
+1.7%
0.00%0.0%
Q2 2021$1,760,000
-23.1%
267,019
-5.5%
0.00%
-33.3%
Q1 2021$2,290,000
+21.7%
282,692
-3.1%
0.00%0.0%
Q4 2020$1,882,000
+101.9%
291,725
+12.7%
0.00%
+200.0%
Q3 2020$932,000
-30.1%
258,927
-10.6%
0.00%
-50.0%
Q2 2020$1,333,000
+70.5%
289,701
+26.3%
0.00%0.0%
Q1 2020$782,000
-26.7%
229,317
+9.7%
0.00%0.0%
Q4 2019$1,067,000
+113.4%
208,965
+1.2%
0.00%
+100.0%
Q3 2019$500,000
+16.0%
206,423
+4.0%
0.00%0.0%
Q2 2019$431,000
-13.5%
198,494
+8.1%
0.00%0.0%
Q1 2019$498,000
-45.0%
183,673
-2.7%
0.00%
-50.0%
Q4 2018$906,000
-24.1%
188,828
+49.8%
0.00%0.0%
Q3 2018$1,194,000
-2.1%
126,034
+0.6%
0.00%0.0%
Q2 2018$1,219,000
+22.0%
125,233
+31.9%
0.00%0.0%
Q1 2018$999,000
+71.6%
94,932
+4.5%
0.00%
+100.0%
Q4 2017$582,000
-23.7%
90,849
-9.0%
0.00%
-50.0%
Q3 2017$763,000
+9.3%
99,786
+1.6%
0.00%0.0%
Q2 2017$698,000
+76.7%
98,176
-3.7%
0.00%
+100.0%
Q1 2017$395,000
+82.0%
101,943
-4.0%
0.00%0.0%
Q4 2016$217,000
-23.9%
106,169
-0.0%
0.00%0.0%
Q3 2016$285,000
-16.2%
106,196
-3.8%
0.00%0.0%
Q2 2016$340,000
-57.6%
110,371
+17.3%
0.00%
-50.0%
Q1 2016$801,000
-37.1%
94,059
+0.2%
0.00%
-50.0%
Q4 2015$1,273,000
+51.4%
93,829
+7.1%
0.00%
+33.3%
Q3 2015$841,000
-34.1%
87,574
-1.3%
0.00%
-25.0%
Q2 2015$1,276,000
+50.5%
88,757
-6.3%
0.00%
+100.0%
Q1 2015$848,000
+74.1%
94,747
+18.6%
0.00%
+100.0%
Q4 2014$487,000
-44.6%
79,897
-3.8%
0.00%
-66.7%
Q3 2014$879,000
-17.1%
83,042
-7.1%
0.00%0.0%
Q2 2014$1,060,000
-29.0%
89,432
-10.6%
0.00%
-25.0%
Q1 2014$1,494,000
-2.2%
100,037
-3.9%
0.00%
-20.0%
Q4 2013$1,527,000
-14.2%
104,057
-0.5%
0.01%
-16.7%
Q3 2013$1,780,000
+1.2%
104,607
-1.3%
0.01%0.0%
Q2 2013$1,759,000106,0340.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders